SOX2 and glioblastoma: The hyaluronan receptor CD44, which has also been proposed as a SLGC and GBM subtype marker with significance in tumor progression [60] showed varying expression levels in Western blots, in which high CD44 expression was observed for both SLGC cultures with high and low Sox2 levels (Fig 2C).